...
首页> 外文期刊>Neurology. >Normobaric Hyperoxia Combined With Endovascular Treatment for Patients With Acute Ischemic Stroke: A Randomized Controlled Clinical Trial
【24h】

Normobaric Hyperoxia Combined With Endovascular Treatment for Patients With Acute Ischemic Stroke: A Randomized Controlled Clinical Trial

机译:Normobaric Hyperoxia Combined With Endovascular Treatment for Patients With Acute Ischemic Stroke: A Randomized Controlled Clinical Trial

获取原文
获取原文并翻译 | 示例
           

摘要

To investigate the safety and efficacy of normobaric hyperoxia (NBO) combined with endovascular treatment (EVT) in patients with acute ischemic stroke (AIS). In this single-center, proof-of-concept, assessor-blinded, randomized, controlled pilot study, patients with AIS in the acute anterior circulation with large vessel occlusion who had an indication for EVT were randomly assigned to the EVT group or the NBO + EVT group. The NBO + EVT group was given 100% oxygen through a face mask initiated before vascular recanalization (10L/min for 4 hours), while the EVT group was given room air. The primary endpoint was infarct volume measured by MRI within 24–48 hours after randomization. A total of 231 patients were screened, and 86 patients were randomized into a ratio of 1:1 (EVT group, n = 43; NBO + EVT group, n = 43). The median infarction volume of the NBO + EVT group at 24–48 hours after randomization was significantly smaller than that of the EVT group (median 20.1 vs 37.7 mL, p < 0.01). The median mRS score at 90 days was 2 for the NBO + EVT group when compared with 3 for the EVT group (adjusted value 1.8, 95% CI 1.3–4.2; p = 0.038). Compared with the EVT group, the NBO + EVT group had a lower incidence of symptomatic intracranial hemorrhagic (7% vs 12%), mortality (9% vs 16%), and adverse events (33% vs 42%); however, such a difference was not statistically significant. NBO in combination with EVT seems to be a safe and feasible treatment strategy that could significantly reduce infarct volume, improve short-term neurobehavioral test score, and enhance clinical outcomes at 90 days when compared with EVT alone in patients with AIS. These observations need to be further confirmed by a large, multicenter, randomized clinical trial. NCT03620370. This pilot study provides Class I evidence that NBO combined with standard EVT decreases infarction volume in patients with acute anterior circulation stroke.
机译:调查的安全性和有效性normobaric氧过多(NBO)结合血管内治疗患者(EVT)急性缺血性中风(AIS)。单中心、概念、随机、对照、assessor-blinded飞行员研究AIS患者在急性前循环与大血管闭塞EVT被随机分配到的迹象EVT组或NBO + EVT组。通过面对EVT组给予100%的氧气面具之前启动血管再通4小时(10 l / min),而EVT组室内空气。核磁共振后24 - 48小时内体积测量随机化。筛选,86名患者被随机分配到一个1:1的比例(EVT组,n = 43;n = 43)。+ EVT组随机化后24 - 48小时之内明显小于EVT的吗集团(中位数20.1 vs 37.7毫升,p < 0.01)。平均分数在90天夫人NBO + 2EVT组相比EVT的3组(调整值为1.8,95%可信区间1.3 - -4.2;与EVT组相比,NBO + EVT组较低的发病率症状性颅内吗出血性(7% vs 12%),死亡率(9% vs 16%),和不良事件(33% vs 42%);差异没有统计学意义。结合EVT似乎是一个安全的和可行的治疗策略显著减少梗塞体积,改善短期神经行为测试成绩,加强临床结果在90天的时候相比之下,独自EVT在AIS患者。这些观察结果需要进一步证实由一个大型多中心,随机临床审判。类我NBO加上标准的证据EVT减少患者的梗死体积急性中风前循环。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号